Yossi Maimon
2019 - Protalix BioTherapeutics
In 2019, Yossi Maimon earned a total compensation of $306.2K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Option Awards | $9,060 |
|---|---|
| Salary | $209,602 |
| Other | $87,586 |
| Total | $306,248 |
Maimon received $209.6K in salary, accounting for 68% of the total pay in 2019.
Maimon also received $9.1K in option awards and $87.6K in other compensation.
Rankings
In 2019, Yossi Maimon's compensation ranked 12,886th out of 13,971 executives tracked by ExecPay. In other words, Maimon earned more than 7.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,886 out of 13,971 | 8th |
Division Manufacturing | 5,226 out of 5,701 | 8th |
Major group Chemicals And Allied Products | 2,051 out of 2,200 | 7th |
Industry group Drugs | 1,766 out of 1,886 | 6th |
Industry Biological Products, Except Diagnostic Substances | 378 out of 389 | 3rd |
Source: SEC filing on April 15, 2020.
Maimon's colleagues
We found six more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2019.
2019
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2019
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2019
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2019
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
2019
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
2019
Eyal Rubin
Protalix BioTherapeutics